The Latest On Transapical: Edwards Talks Up Sapien CAP Data

The non-randomized continued access program, which enrolled 822 transapical patients beyond the original randomized enrollment of 104 transapical patients, tells an improving story for transapical delivery for Sapien.

More from Clinical Trials

More from R&D